摘要
Oxaliplatin is commonly used in chemotherapeutic regimens for colorectal cancer (CRC) after surgical resection. However, acquired chemoresistance seriously affects the curative effect in CRC patients, and the mechanism is still unclear. Here, a circular RNA, circATG4B is identified, which plays an important role in oxaliplatin resistance in CRC. circATG4B expression is found to be increased in exosomes secreted by oxaliplatin-resistant CRC cells. In addition, the results suggest that circATG4B induces oxaliplatin resistance by promoting autophagy. Further in vivo and in vitro studies indicate that the effect of circATG4B is attributed to its potential to encode a novel protein, circATG4B-222aa. Next, circATG4B-222aa is found to function as a decoy to competitively interact with TMED10 and prevent TMED10 from binding to ATG4B, which leads to increased autophagy followed by induction of chemoresistance. Therefore, this study reveals that exosomal circATG4B participates in the decreased chemosensitivity of CRC cells, providing a new rationale for a potential therapeutic target for oxaliplatin resistance in CRC.
学科与关键词
- CAF-derived exosomal lncRNA FAL1 promotes chemoresistance to oxaliplatin by regulating autophagy in colorectal cancerZhu, Sixian; Mao, Jie; Zhang, Xiaoli; Wang, Ping; Zhou, Yi; Tong, Jin; Peng, Hui; Yang, Bei; Fu, Qiang*Digestive and Liver Disease, 2024, 56(2): 330-342.被引 4
- Effective Delivery of siRNA-Loaded Nanoparticles for Overcoming Oxaliplatin Resistance in Colorectal CancerZhou, Yue; Zhang, Qing; Wang, Minjia; Huang, Chengzhi*; Yao, Xueqing*Frontiers in Oncology, 2022, 12: 827891.被引 5
- WBSCR22 confers oxaliplatin resistance in human colorectal cancerYan Dongmei; Tu Linglan; Yuan Haining; Fang Jianfei; Cheng Liyan; Zheng Xiaoliang; Wang XiaojuScientific Reports, 2017, 7: 15443.
